Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding visit

Oncology Briefings™: Identifying and Treating Patients with RET- Rearranged Non–Small Cell Lung Cancer

Release Date: December 18, 2020
Expiration Date: December 18, 2021

Activity Overview

This online activity is designed to provide a concise and focused overview on an important clinical topic and includes information on pathophysiology of RET-positive non–small cell lung cancer (NSCLC), incorporating genomic testing for RET alterations into the diagnostic workup for patients with NSCLC, and recent efficacy and safety data of therapies recommended for the treatment of patients with RET-positive NSCLC. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding visit

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward oncology healthcare professionals who treat patients with lung cancer, including medical oncologists and pathologists. Radiation and surgical oncologists, fellows, nurses, nurse practitioners, physician assistants, and other health care professionals (HCPs) involved in the management of patients with lung cancers will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the role of RET rearrangements/fusions in NSCLC oncogenesis and tumor progression
  • Explain the advantages and challenges associated with testing methods in screening for the presence of RET rearrangements in patients with NSCLC
  • Outline clinical practice guideline recommendations regarding the management of patients with RET rearrangement–positive NSCLC
  • Discuss recent key data reported from clinical trials evaluating the use of RET inhibitors for the treatment of NSCLC

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Justin Gainor, MD
Justin Gainor, MD
Director, Center for Thoracic Cancers
Director of Targeted Immunotherapy
Assistant Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: Justin Gainor, MD, has served as a compensated consultant or received honoraria from Bristol Myers Squibb, Genentech, Ariad/Takeda, Loxo/Lilly, Blueprint, Oncorus, Regeneron, Gilead, AstraZeneca, Pfizer, Incyte, Novartis, Merck, Agios, EMD Serono, Amgen, and Array; research support from Novartis, Genentech/Roche, and Ariad/Takeda; institutional research support from Bristol Myers Squibb, Tesaro, Moderna, Blueprint, Jounce, Array Biopharma, Merck, Genentech, AstraZeneca, Adaptimmune, Novartis, and Alexo; and has an immediate family member who is an employee of Ironwood Pharmaceuticals.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By